For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Blog
This week in health care policy: October 16–23, 2026
Medical innovation FDA approves several innovative treatments. Last week, the FDA granted accelerated approval to GSK’s Jemperli for certain untreated…
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Search Posts
Tulsa Business
Latest Study, Again, Shows Small Car Safety Risk
Tulsa Business
Food Safety Law and Small Producers, Cont’d
Newsletter
Somali Pirates, GM Executives and FDA Regulators
The U.S. military considers attacking Somali pirate bases. Treasury officials instruct General Motors to plan for bankruptcy. The Food and Drug Administration reconsiders its ban…
Blog
Jack Dreyfus, FDA Reform Pioneer
My colleague John Berlau wrote a nice obituary of mutual fund pioneer Jack Dreyfus that was published in Investor’s Business Daily earlier this week.
News Release
Study Argues for Protection of Incremental Drug Advances
Normal 0 false false false MicrosoftInternetExplorer4 Normal 0 false false false MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:"";…
Blog
Baptist-Bootlegger Alliance on Tobacco
In today’s Washington Examiner, Tim Carney has an excellent column on how the bill to place tobacco under FDA regulation would reduce competition in…